Article
Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect.
Human gene therapy - 1 Jul 2001
Harrison D, Sauthoff H, Heitner S, Jagirdar J, Rom W N, Hay J G
Abstract excerpt
Strategies to target viral replication to tumor cells hold great promise for the treatment of cancer, but even with replicating adenoviruses complete tumor responses are rarely achieved. To evaluate replicating adenoviral vectors, we have used A549 human lung cancer nude mouse xenografts as a model system. Intratumoral injection of wild-type adenovirus (Ad309) significantly reduced tumor growth from day 14 (p =...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
